STAT

MARCH 28, 2024

The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason. But last year, its staff sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’

Drug Pricing 362

Drug Pricing 362

Pharma Times

MARCH 28, 2024

The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases

151

151

STAT

MARCH 28, 2024

The financial ties between drug and device makers and some physicians remains pervasive, despite concerns such relationships may influence medical practice, according to a new analysis of payments made over a recent 10-year span. From 2013 to 2022, pharmaceutical and device companies made more than 85 million payments totaling $12.1 billion to approximately 826,300 physicians.

352

352

Pharma Times

MARCH 28, 2024

Healthcare agencies can submit their entries free of charge with a deadline of 30 April

143

143

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

MARCH 28, 2024

WASHINGTON — There’s a fight brewing over the future of decaf coffee. Consumer health advocates are petitioning the Food and Drug Administration to ban a key chemical, methylene chloride, used to decaffeinate coffee beans. While the chemical is almost entirely removed during the decaffeination process, advocates say that a little-known nearly 66-year-old federal law mandates the agency ban the additive because it has been proven to cause cancer in rodents.

351

351

Pharma Times

MARCH 28, 2024

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

143

143

PharmaVoice

MARCH 28, 2024

With Zola Therapeutics, Krieg plans to design and sell a series of cancer immunotherapies without the help of outside investors, he told BioPharma Dive.

130

130

STAT

MARCH 28, 2024

Oprah Winfrey, true to form, is forcing America to yet again grapple with a complex topic: weight loss. Her full-throated endorsement on national television last week for using GLP-1 drugs like Ozempic and Wegovy to treat obesity has opened the door for an important conversation about the use of these drugs for people struggling with their weight. As a physician focused on obesity and metabolic disorders, I was troubled by Oprah’s support for these drugs.

318

318

PharmaVoice

MARCH 28, 2024

Novo Nordisk’s acquisition of Cardior Pharmaceuticals is a bet on new approaches to cardiovascular disease, says Cardior CEO Claudia Ulbrich.

130

130

STAT

MARCH 28, 2024

The United Kingdom has released comprehensive data showing which institutions have failed to register their clinical trials, a move that was hailed by transparency advocates who say this marks the first time that a country has taken such a step. Last week, the Health Research Authority posted complete registration information for 1,545 trials, including the name of the study, the sponsor, and registration number for the trial.

301

301

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

BioPharma Dive

MARCH 28, 2024

Xilio will get just over $40 million from Gilead in return for a license to its experimental IL-12 immunotherapy. The biotech is also discontinuing other work and laying off staff.

114

114

STAT

MARCH 28, 2024

Top of the morning to you and a fine one it is. Despite cloudy skies hovering over the Pharmalot campus, our spirits remain sunny. How so? We will trot out a bit of wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” So while you tug on the ribbon, we will proceed by brewing another cup of stimulation.

Diabetes 283

Diabetes 283

pharmaphorum

MARCH 28, 2024

Explore the cutting-edge innovations featured at WIRED Health 2024, including insights on Alphafold, clean air technology, and Lingo. Stay informed about the latest disruptors shaping the future.

114

114

STAT

MARCH 28, 2024

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.

282

282

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Guardian - Pharmaceutical Industry

MARCH 28, 2024

Drug companies urged to ‘release stranglehold’ on medicines such as Ozempic and Trulicity, as millions are priced out of treatment Drug companies are pricing diabetes medicines at almost 400 times the level necessary to make a profit, according to a new study. Researchers said it would also be possible for modern insulin pens, which are safer and offer more accurate doses than vials and syringes, to be used even in low-income countries if pharmaceutical firms “put people before their astronomica

Diabetes 112

Diabetes 112

STAT

MARCH 28, 2024

Today is the inaugural publishing day for Adam’s Biotech Scorecard — a subscriber-only newsletter offering senior reporter Adam Feuerstein’s no-holds-barred perspective on the rapidly shifting world of biotech. Sign up to get it in your inbox here. Hello! It’s Meghana. Today, we’re reading about the world’s costliest drug, plus we learn about immune senescence and a potential cause for a kidney autoimmune disease.

Immunity 263

Immunity Immunization Drug Pricing Drug Development 263

pharmaphorum

MARCH 28, 2024

Scientists say a test for motor neuron disease, based on an aptamer for biomarker TDP-43 in brain tissue, could detect at-risk people before symptoms develop.

111

111

BioPharma Dive

MARCH 28, 2024

The agency gave Akebia’s drug an OK after receiving more safety data, but imposed a strict boxed warning for its use that may limit uptake.

111

111

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

EMCrit Project

MARCH 28, 2024

All the literature goodness for March 2024 EMCrit Project by Scott Weingart, MD FCCM.

111

111

pharmaphorum

MARCH 28, 2024

New data for Beckley Psytech's psychedelic therapy for treatment-resistant depression builds anticipation for a phase 2b readout later this year

105

105

Pharmaceutical Commerce

MARCH 28, 2024

The latest news for pharma industry insiders.

105

105

Express Pharma

MARCH 28, 2024

ICRA expects the revenues of its sample set of 25 Indian pharma companies (which account for ~60 per cent of the overall Indian pharma industry) to grow by 8-10 per cent in FY2025, post a YoY increase of 13-14 per cent in FY2024. Following the high base of FY2024, the revenue growth momentum from the US and Europe markets is expected to moderate to 8-10 per cent and 7-9 per cent, respectively, from the YoY expansion of 18-20 per cent and 16-18 per cent, respectively, estimated for FY2024.

105

105

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

MARCH 28, 2024

Akebia’s Vafseo has been approved in the US as a treatment for anaemia caused by chronic kidney disease in dialysis patients, the first direct rival to GSK’s Jesduvroq.

104

104

Express Pharma

MARCH 28, 2024

Dr. Satish Wagh, Chairman & MD, Supriya Lifescience speaks to Express Pharma on the company’s strategy to achieve a turnover of INR 1000 crore within the next five years, and how PLI schemes are helping pharma manufacturers to backward integrate. India is now being seen as a focused pharma manufacturer, according to Dr Wagh and explains how these moves will ensure that the pharma sector will be a major contributor to India’s economy.

104

104

pharmaphorum

MARCH 28, 2024

Study finds AI analysis of Google Street View images could reveal how built environment factors affect the risk of cardiovascular disease

103

103

The Pharmacist

MARCH 28, 2024

The provision of pharmacy services is currently balanced ‘in a different way’ amid community pharmacy closures and a rise in distance selling pharmacies (DSPs), NHS England’s director for primary care has suggested. Dr Amanda Doyle was speaking as part of the Health and Social Care Committee’s (HSCC’s) pharmacy inquiry this week when she said that […] The post NHSE: Different ‘balance’ in pharmacy provision amid closures and rise in DSPs appeared first on The Pharmacist.

Community Pharmacies 99

Community Pharmacies 99

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pulses

MARCH 28, 2024

By: Cherie Lucas, PhD, BPharm, Grad Cert Edu Stud (Higher Educ), MPS and Dr Arcelio Benetoli , BPharm, MSc, PhD How is Professionalism Defined? Professionalism is a complex and multifaceted construct. Many definitions in the literature embody what this entails. Values of professionalism in pharmacy include altruism and core norms, such as self-reflection, along with other attributes, behaviors, ethical conduct, and standards that pharmacists must epitomize daily. 1 This extends beyond the techni

Communication 98

Communication 98

European Pharmaceutical Review

MARCH 28, 2024

A paper published in Applied Sciences has described a quality risk assessment methodology for application in sterile PET radiopharmaceutical production under Good Manufacturing Practice (GMP) regulations. According to research highlighted in the paper, applying quality standards such as GMP and ISO 9001 “guarantees the quality and safety of a radiopharmaceutical and contributes to optimising the performance and efficacy of the entire production process.

98

98

Pharmaceutical Technology

MARCH 28, 2024

Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with retinitis pigmentosa (RP).

98

98

Drug Channels

MARCH 28, 2024

Today’s guest post comes from Bill Dupere, SVP of Product Development & Partnerships at Mercalis. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management